Xeris Biopharma Holdings
XERS
XERS
103 hedge funds and large institutions have $128M invested in Xeris Biopharma Holdings in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $120M → $128M (+$8.24M)
4.35% more ownership
Funds ownership: 32.89% → 37.25% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
103
Holding in Top 10
2
Calls
$4.23M
Puts
$320K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$5.81M | |
| 3 | +$3.11M | |
| 4 |
Goldman Sachs
New York
|
+$1.27M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.2M |
Top Sellers
| 1 | -$3.12M | |
| 2 | -$3.1M | |
| 3 | -$1.05M | |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$1M |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$695K |